7.990
+0,00%
2026-10-19
Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +294.7% | +140.1% | 2 / 3 | +39.0% | +2.93 pp | +4.26 pp | +9.8% | 2.19 | 4.94 | 735 | +39,0% | 48,2 | +297,2% | 4.94 | 7.20 | −31,4% |
| Pts | 12 | 12 | 8 | 12 | 8 | 12 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 7.990 (close price on 2026-10-19)EPS (TTM): 1.617
Financial charts
1.Revenue & growth
VND bn735Q2/26
1.Revenue & growth
VND bn735Q2/26
2.Profit & growth
VND bn48,1Q2/26
3.Profit mix (Penman)
VND bn82,7Q2/26
4.Margins & cost structure
%14.3%Q2/26
5.Returns & cash cycle
% · days7.8%Q2/26
6.Earnings quality & cash
VND bn-14,7Q2/26
7.Asset structure
VND bn3.211Q2/26
8.Funding & debt health
VND bn · times3.211Q2/26
9.Revenue backlog
VND bn120Q2/26
10.Valuation
times · %4,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.068Q2/26
Adjusted EPS growth, latest quarter
295%
Average adjusted EPS growth, 3 quarters
140%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26